Korean J Transplant.  2022 Nov;36(Supple 1):S178. 10.4285/ATW2022.F-3040.

Result of biomarker and three-dimension Vincent research of liver volume changes after prosthetic valve endocarditis treatment

• Batdelger A
• Byambaragchaa M
• Radnaabazar M
• Amankyeldi Y
• Chogsom M

• KMID: 2535694
• DOI: http://doi.org/10.4285/ATW2022.F-3040

Abstract

Background
Liver cancer is the most commonly diagnosed cancer in Mongolia, and in 2018, a total of 2,312 new cases were diagnosed nationwide, accounting for 38.1% of all cancers, the highest prevalence, an increase of 4% compared to 2017. In developed countries, 2–5 new cases per 100,000 people are diagnosed, of which 93 are in females and 130 in males, and this number is expected to increase. About 80% of newly diagnosed liver cancers are diagnosed in stages III and IV. Large cirrhosis in patients with cirrhosis and liver cancer increases the risk of postoperative liver failure and is a major cause of postoperative mortality. Prosthetic valve endocarditis (PVE) treatment is a very simple procedure that is very different from surgery to open the abdomen and separate the hepatic portal vein from the hepatic vein, and requires precise skills to puncture the hepatic venous vein under ultrasound guidance. With the introduction of this procedure, new surgical possibilities, patient complications, and complications associated with any surgery have been drastically reduced.
Methods
The study will sample a total of 120 clients who underwent major liver resection at the NCCD in 2020–2022 and underwent major liver resection one month after PVE treatment. This study will be conducted using a one-moment survey model based on a destructive research hospital.
Results
The results of our study are important in the selection of patients for interventional radiology and liver surgery practice.
Conclusions
The results of our study are important in the selection of patients for interventional radiology and liver surgery practice. It will help you choose a treatment that is less harmful. Plasma levels of Mac-2 binding protein glycan isomer help to predict factor the outcome of PVE treatment. It will be used in the future to develop recommendations for the treatment of large liver resections.